The Bitter Pill

The Official Blog of UNITE – uniteforlife.org

ADHD and Internet Addiction SCAM!

Inventor of ADHD confesses “ADHD is a prime example of a ficticious disease”. The APA turns the hoax Ïnternet Addiction Disorder” into a DSM billing bible diagnosis!

Filed under: 'ADHD', addiction, antipsychotics, APA, big pharma, child endangerment, disease mongering, drugging children, DSM, Fraud, patient deaths, pharma payments to doctors, Ritalin, schizophrenia, screening, SSRI, , , , ,

MOTHERS Act and DBSA – pHARMa Front Group – Who cares about money?

FRONT GROUP FINANCIAL INFORMATION: DBSA

This research was conducted by Evelyn Pringle… I hope you can note the inserted comments from her and look below to read my comments, which I’ll leave off the article portion and put in the comment box.

Depression and Bipolar Support Alliance

2005 Annual Report

http://www.dbsalliance.org/pdfs/05annualreport.pdf

Sue Bergeson, President, DBSA

ALLIANCE LEAGUE ($500,000 AND ABOVE)

Wyeth Pharmaceuticals

LEADERSHIP CIRCLE ($150,000-$499,999)

Abbott Laboratories
AstraZeneca Pharmaceuticals
Bristol-Myers Squibb Company
Cyberonics, Inc.
Eli Lilly and Company Foundation
Pfizer Inc


FOUNDERS CLUB ($10,000-149,999)

Forest Laboratories
GlaxoSmithKline
Janssen Pharmaceutica Products
Neuronetics, Inc.
Shire Pharmaceuticals Group


ADVOCATE COUNCIL ($5,000-9,999)

Dr. and Mrs. Edward M. Scolnick


PLATINUM ($1,000-4,999)

Merck & Co. Inc.
Lori L. Altshuler, M.D.
Kay Redfield Jamison, Ph.D.
A. John Rush, M.D.
Mr. Robert C. Schwartz


GOLD ($500-999)

Dr. and Mrs. Mark S. Bauer
Gregory Simon, M.D.


SILVER ($150-499)

Johnson and Johnson
Joseph Biederman, M.D.

Linda L. Carpenter, M.D.
Dr. Ron C. Melzer
National Association of Boards of Pharmacy
Charles O’Brien, M.D.


MATCHING GIFT COMPANIES

GlaxoSmithKline
Merck & Co. Inc
Pfizer Foundation

EMPLOYEE GIVING

Abbott Laboratories

======================

2006

Drug company money to Depression and Bipolar Support Alliance in 2006

(Evelyn’s note:

The 2006 Annual Report for the Depression and Bipolar Support Alliance shows that AstraZeneca gave the group more than $500,000 in 2006. Companies that gave between $150,000 and $499,000 included Abbott Laboratories, Bristol-Myers Squibb and Wyeth Pharmaceuticals. Forest Laboratories, GlaxoSmithKline, Janssen, Pfizer, and Shire Pharmaceuticals each gave between $10,000 and $149,000.)

2006 Annual Report

http://www.dbsalliance.org/pdfs/2006AnnualReport.pdf

=======================

2007

Depression and Bipolar Alliance

Annual Report

http://www.dbsalliance.org/site/DocServer/FINAL_AnnualReport07.pdf?docID=2761

This list reflects donations received through December 31, 2007.

LEADERSHIP CIRCLE ($150,000-$499,999)

AstraZeneca
Pfizer Inc
Wyeth Pharmaceuticals

FOUNDERS CLUB ($10,000-149,999)

Abbott Laboratories
Cyberonics, Inc.
Elli Lilly and Company
Forest Laboratories
GlaxoSmithKline
National Association of State
Mental Health Program Directors
Organon, Inc.
Otsuka American Pharmaceutical, Inc

PLATINUM ($1,000-4,999)

Abbott Laboratories Employee Giving Campaign

GOLD ($500-999)

Lori L Altshuler, MD
David Dunner, MD
Kay Redfield Jamison, PhD
A. J. Rush, MD
Martha Sajatovic, MD
Gregory Simon, MD, MPH
TAP
Dr. James Walker

SILVER ($150-499)

Dr. and Mrs. Paul Berkowitz
Joseph Biederman, MD
Dr. Judith A. A. Cook
Dr. and Mrs. Alan Harris
Dr. Roger W. Helfrich
Nada l. Stotland, MD

CONTRIBUTORS TO THE REBECCA LYNN CUTLER LEGACY OF LIFE FOUNDATION

Abbott Laboratories
AstraZeneca
Eli Lilly and Company
Janssen
Organon, Inc.
Pfizer Inc
Wyeth Pharmaceuticals

EMPLOYEE GIVING COMPANIES

Abbott Laboratories
Eli Lilly and Company
GlaxoSmithKline
Merck Partnership for Giving
Pfizer Foundation

2007 at a Glance: How We Met Our Mission

(Among other things listed are):

Promoted Melanie Blocker-Stokes Postpartum Depression Research & Care Act at invitation of Rep. Bobby Rush (D-Ill.)

Promoted MOTHER’s Act at invitation of Sen. Dick Durbin (D-Ill.)

Launched consumer smoking cessation initiative, funded by Robert Wood Johnson
Foundation’s Smoking Cessation Leadership Center

First-ever DBSA Hope Award for lifetime achievement presented to Frederick K.
Goodwin, MD, & Kay Redfield Jamison, PhD

Active in development & promotion of “Depression Is Real” PSA campaign

=======

DBSA 2007 Fall Newsletter “Outreach”

The issue states: “DBSA gratefully acknowledges its Leadership Circle, Organizations that contributed a minimum of $150,000 during 2007.”

ABBOTT LABORATORIES
ASTRAZENECA PHARMACEUTICALS
PFIZER INC
WYETH PHARMACEUTICALS

http://www.dbsalliance.org/pdfs/outreach/Outreach_Fall2007.pdf

Under “Our 2007 Legislative Milestones” it lists:

DBSA was honored to be asked personally by Senator Dick Durbin (D-Ill.) and Representative Bobby Rush (D-Ill.) to help introduce the postpartum legislation in Illinois.

=========

DBSA Spring 2008 Newsletter “Outreach”

The issue states: “DBSA gratefully acknowledges its Leadership Circle, Organizations that contributed a minimum of $150,000 during 2007.”

ABBOTT LABORATORIES
ASTRAZENECA PHARMACEUTICALS
PFIZER INC
WYETH PHARMACEUTICALS

http://www.dbsalliance.org/pdfs/outreach/Outreach_2008Spring.pdf

It also publishes the following message which explains where some of the drug money went:

Speaking Out for New Moms

Six years ago, after giving birth to her first child, a successful 41-year-old sales manager plunged to her death from a Chicago hotel’s 12th floor as firefighters pleaded with her. Melanie Blocker-Stokes took her own life, despite medical help and the support of family and friends.

Melanie’s tragedy soon prompted legislation in both the U.S. House and Senate. If passed, the Melanie-Blocker Stokes Postpartum Depression and Research Act and the MOTHER’s Act will help the families and women afflicted by postpartum depression (PPD) through lifesaving educational programs and screening services.

In January, DBSA sent an Advocacy Alert asking you to write your legislators in support of these PPD bills. Thousands of you sent letters to Congress through our Legislative Action Center (LAC). As time went on, instead of contacting individual legislators, you began to ask specific congressional committees (like the House Committee on Energy and Commerce), to support a vote rather than just a bill.

Unfortunately, rumors and lies began circulating on the Web, as outspoken opponents began asking people not to support these bills. While they called themselves “experts,” none of them had any expertise in mental health or any PPD-related field. They claimed the legislation was just a conspiracy by big pharmaceutical companies to push new moms to take unnecessary medication.

Tell that to the more than 800,000 women who will develop a diagnosable postpartum mood disorder this year! To debunk these myths, on April 8, DBSA sent you another alert marked “Urgent.” Your response has been nothing less than amazing-unprecedented, Web experts tell us! Just nine hours after our alert, you’d sent 1,200 letters to legislators.

In the next two days, you sent 6,300 more. After one month, you’d sent over 15,000 letters speaking out against the PPD rumors! And, for the first time, other groups are proactively joining us.

Organizations and blog sites like Postpartum Support International (PSI), Postpartum Progress, Moms Speak Up, Becoming Me, Beyond Blue and EmpowerHer are linking their readers to our LAC so that even more letters reach Congress.

Did you know that as few as five letters can make a difference in how your legislator votes? Even if you’ve already sent a letter supporting PPD legislation, please send another.

Help us reach the 20,000 mark for letters supporting PPD legislation! Write Congress today at http://www.DBSAlliance.org/Advocacy.

================

Some of the drug money funneled through the DBSA is apparently being spent the same way this year by utilizing the postpartum front groups operating on the internet.

==========

Note from Evelyn:

On March 10, 2009, Katherine Stone’s headline on the Postpartum Progress Blog read:

“It’s Petition Signing Time!  Get Out Your Virtual Pen & Support Women with PPD”

Her blog reports “that Susan Stone over at Perinatal Pro is alerting everyone to the new petition created by the Depression and Bipolar Support Alliance to support the Melanie Blocker Stokes MOTHERS Act.  She states that last year’s petition generated more than 24,000 signatures.  The petition has been reintroduced this year to try and get this legislation passed once again.”

The blog carries a live link to an advocacy alert page where “you can scroll down, enter your zip code and generate letters of support in a matter of seconds for the Melanie Blocker Stokes MOTHERS Act that will be sent to your local Congresspeople and Senators.”

Ms Stone further advises: “I just sent my letters.  I know you’re thinking “but I already did that last year.”  Well that was then and this is now.  Do it again.”

Filed under: "prevention", Amy Philo, antidepressants, antipsychotics, big brother, Birth Defects, child endangerment, Christian Delahunty, Congress, dead babies, drugging children, ECT, Effexor in pregnancy, Elizabeth Torlakson, eugenics, experimentation, Harry Reid, Indiana, Isaac Philo, Manie, Melanie Stokes, mothers act, Paxil in pregnancy, pharma payments to doctors, pharmacology, PPD, Pregnancy, profit,

Forest Labs’ Lexapro Flap Over JAMA Article Will Likely Be Examined by the Feds

Background:

JAMA Editor Upset With Researcher For Pushing Conflict Disclosure

JAMA Editor Calls Critic a Nobody and a Nothing

Article:

http://industry.bnet.com/pharma/10001372/forest-labs-lexapro-flap-over-jama-article-will-likely-be-examined-by-the-feds/

By Jim Edwards | March 16th, 2009 @ 11:35 am

An editor of the Journal of the American Medical Association called a university professor “a nobody and a nothing” after he pointed out, correctly, that a JAMA author had failed to disclose a financial relationship with Forest Labs in an article about Lexapro, according to the WSJ.

The spat, although entertaining, will probably be examined carefully by the U.S. Department of Justice, which is currently suing Forest for, among other things, the “placement” of positive news stories in the media about Lexapro.

The author, Dr. Robert Robinson of the University of Iowa, had published a study of the use of Lexapro vs. therapy in patients who had suffered strokes, to see if either helped the patients avoid becoming depressed. The study concluded that both helped, with only 9 percent of Lexapro patients becoming depressed and 12 percent of those on therapy. About 22 percent of those who received a placebo became depressed.

Jonathan Leo, associate professor of neuroanatomy at Lincoln Memorial University, noticed that Robinsons’s study contained something strange:

… we were confused by a subtle but seemingly critical omission from the published paper. While the authors compared both Lexapro and therapy to placebo, they did not report on the direct comparison of therapy to Lexapro …

Leo pointed this out in a rival publication, the British Medical Journal. And then the folks at JAMA seem to have gone completely crazy. WSJ:

Leo says he received an angry call from JAMA executive deputy editor Phil Fontanarosa last week, shortly after Leo’s article was published on the BMJ Web site. “He said, ‘Who do you think you are,’ ” says Leo. “He then said, ‘You are banned from JAMA for life. You will be sorry. Your school will be sorry. Your students will be sorry.”

The call from Fontanarosa was followed up by ones from JAMA editor-in-chief Catherine DeAngelis to Leo’s superiors, Leo says. He said she asked his superiors to get him to retract his article in the BMJ.

… “This guy is a nobody and a nothing” she said of Leo. “He is trying to make a name for himself. Please call me about something important.” She added that Leo “should be spending time with his students instead of doing this.”

When asked if she called his superiors and what she said to them, DeAngelis said “it is none of your business.” She added that she did not threaten Leo or anyone at the school.

As Leo notes, however, in addition to not doing a head-to-head comparison between Lexapro and therapy, Robinson also failed note that he had taken money from Forest Labs. Leo:

In a letter to JAMA, we pointed this out. Five months later, our letter was published along with an acknowledgement from the original authors that indeed the difference between therapy and medication was not statistically significant.

You can read the JAMA correction here.

Filed under: pharma payments to doctors, , ,

Postpartum Support International Reliance on Emory Studies to Justify Pregnant and Nursing Mothers’ Use of Drugs

Evelyn Pringle tipped me off to another connection between Postpartum Support International (PSI) and industry-influenced information. If you go to this link on their site, you can see information being forwarded to moms from the Emory Women’s Mental Health Program as well as Massachussetts General Hospital (who also takes money from drug companies while simultaneously promoting The MOTHERS Act and claiming that drugs like Paxil are safe for pregnancy).

Charles Grassley’s investigations into major psychiatric opinion leaders have consistently demonstrated undisclosed financial conflicts of interest. The latest investigation led to Dr. Nemeroff’s voluntary surrender of his post at Emory as the head of the Psychiatry Department. Grassley found Nereroff made millions of dollars off SRRI makers and only disclosed a small fraction of the amount.

Here are some of the Nemeroff articles that PSI links to: 

Sertraline in the Treatment of Women with Postpartum Onset Major Depression
Stowe Z.N., Casarella J., Landry J.C., and Nemeroff C.B. (1995) “Sertraline in the Treatment of Women with Postpartum Onset Major Depression”. Depression. 3:49-55. 

Women at Risk for Postpartum Depression
Stowe Z.N., and Nemeroff C.B. (1995) “Women at Risk for Postpartum Depression”. American Journal of Obstetrics and Gynecology. 173:639-645.

Diagnosis and Treatment of Postpartum Depression
Winn S.S., Stowe Z.N., and Nemeroff C.B. “Diagnosis and Treatment of Postpartum Depression”. Clinical Advances in the Treatment of Psychiatric Disorders. 10:1-11(Jan/Feb 1996)

Depression During Pregnancy and the Puerperium
Llewellyn A., Stowe Z.N., and Nemeroff C.B. (1997) “Depression During Pregnancy and the Puerperium”. Journal of Clinical Psychiatry. 58 [suppl. 15]:26-32.

The Use of Lithium and Management of Women with Bipolar Disorder During Pregnancy and Lactation
Llewellyn A., Stowe Z.N., and Nemeroff C.B. (1998) “The Use of Lithium and Management of Women with Bipolar Disorder During Pregnancy and Lactation”. Journal of Clinical Psychiatry. 59 [suppl 6]:57-64.

Paroxetine in Breast Milk and Nursing Infants
Stowe Z.N., Cohen L.S., Hostetter A, Ritchie J.C., Owens M.J., and Nemeroff C.B. (2000) “Paroxetine in Breast Milk and Nursing Infants”. American Journal of Psychiatry. 157:185-189.

Parental Depression: Animal Models of an Adverse Life Event
Newport DJ, Stowe ZN, Nemeroff CB. (2002) Parental depression: animal models of an adverse life event. American Journal of Psychiatry. 159(8): 1265-1283.

The Pharmacokinetics of Sertraline Excretion into Human Breast Milk: Determinants of Infant Serum Concentrations
Stowe ZN, Hostetter AL, Owens MJ, Ritchie JC, Sternberg K, Cohen LS and Nemeroff CB. (2003) “The Phamacokinetics of Sertraline Excretion into Human Breast Milk: Determinants of Infant Serum Concentrations”. J Clinical Psychiatry. 64(1):73-80.

Alterations in Platelet Serotonin Transporter Binding in Women with Postpartum Onset Major Depression
Newport DJ, Owens MJ, Knight DL, Ragan KA, Morgan N, Nemeroff CB and Stowe ZN. (2004) Alterations in Platelet Serotonin Transporter Binding in Women with Postpartum Onset Major Depression. J Psychiatr Res 38: 467-473.

Psychopharmacology During Pregnancy and Lactation
Newport DJ, Stowe ZN. Psychopharmacology during pregnancy and lactation. In Schatzberg A, Nemeroff CB, eds. (2006) Essentials of Clinical Psychopharmacology, Second Edition. Washington DC: American Psychiatric Publishing, Inc. pp 745-77.

Atypical Antipsychotic Administration During Late Pregnancy: Placental Passage and Obstetrical Outcomes
Newport DJ. Calamaras MR. DeVane CL. Donovan J. Beach AJ. Winn S. Knight BT. Gibson BB. Viguera AC. Owens MJ. Nemeroff CB. Stowe ZN. (August, 2007) Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. American Journal of Psychiatry. 164(8):1214-20.

Persistent Auditory Hallucinations that are Unresponsive to Antipsychotic Drugs
Nicolson SE, Mayberg HS, Pennell PB, Nemeroff CB. (2006) Persistent auditory hallucinations that are unresponsive to antipsychotic drugs. Am J Psychiatry. 163(7):1153-1159.

Recent Advances in the Neurobiology of Neuropeptides: Focus on Corticotropin-Releasing Factor
Nemeroff CB and Owens MJ. (1986) “Recent advances in the neurobiology of neuropeptides: focus on corticotropin-releasing factor”. Biological Psychiatry. 1985. (Shagass et al., Eds.). Elsevier Publishing, Amsterdam, 103-105.

Preclinical and Clinical Studies with Corticotropin-Releasing Factor: Implications for Affective Disorders
Owens MJ and Nemeroff CB. (1988) “Preclinical and clinical studies with corticotropin-releasing factor: Implications for affective disorders”. Psychopharmacology Bulletin 24:355-359.

Reduced Corticotropin-Releasing Factor (CRF) Binding Sites in the Frontal Cortex of Suicides
Nemeroff CB, Owens MJ, Bissette G, Andorn AC and Stanley M. (1988) “Reduced corticotropin-releasing factor (CRF) binding sites in the frontal cortex of suicides”. Archives of General Psychiatry 45:577-579.

Acute Effects of Alprazolam and Adinazolam on the Concentrations of Corticotropin-Releasing Factor in the Rat Brain
Owens MJ, Bissette G and Nemeroff CB. (1989) “Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain”. Synapse 4:196-202.

Neurotransmitter Regulation of CRF Secretion In Vitro
Owens MJ and Nemeroff CB. (1989) “Neurotransmitter regulation of CRF secretion in vitro. Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide “(EB DeSouza and CB Nemeroff, Eds.). CRC Press, Inc., Boca Raton, FL, 107-114.

Postnatal Development of Brain Corticotropin-Releasing Factor Receptors in the Rat
Pihoker C, Cain ST, Owens MJ and Nemeroff CB. (1991) “Postnatal development of brain corticotropin-releasing factor receptors in the rat”. Horizons in Endocrinology Volume II. Serono Symposia 76, (M Maggi and V Geenen, Eds.). Raven Press, NY.

Excretion of Sertraline in Human Breast Milk and Nursing Infants
Stowe ZN, Owens MJ, Landry JC, Kilts CD, Ely T, Llewellyn A and Nemeroff CB. (1997) Excretion of Sertraline in Human Breast Milk and Nursing Infants. American J. Psychiatry 154:1255-1260.

The Effects of Acute Antipsychotic Drug Administration on the Neurotensin System of the Developing Rat Brain
Kinkead B, Owens MJ and Nemeroff CB. (2000) “The effects of acute antipsychotic drug administration on the neurotensin system of the developing rat brain”. Brain Research Dev Brain Res 124:1-10.

 

The list goes on, but I think you get the idea.

Filed under: antidepressants, antipsychotics, Charles Grassley, child endangerment, experimentation, Julie Edgington, Manie, MGH, mothers act, Paxil in pregnancy, pharma payments to doctors, PPD, Pregnancy, , , , , ,

How Little / Much Isaac and I (and others around us) MATTER To My Doctors

According to research from the Pioneer Press website – where pharma payments to physicians are being documented in a database (2002 on…):

The OBGYN who prescribed me Zoloft and gave me samples of 50 mg tabs after having REMOVED the warning label…

Accepted $967 from pharmaceutical companies before his retirement in 2005. In 2004, he took $766 from pharma, and in 2005, $200. 

2004 was the year he prescribed me Zoloft following a brief approximately one-minute-long conversation. 

This is how little I mattered to him. Not enough time to talk to me – but enough time to bother to hand me drugs that could kill me and my baby. But he had enough time to do ‘education’ and attend dinners with pharma sponsors, and to fill out the reimbursement form for his $100 dinner or whatever the procedure is to get money from pharma.

Since he retired in 2005 (or 2006?) after coming down with an indiagnosable mystery disease… that’s where the Pioneer Press records end.

Now let’s have a look at the shocking record of payments to my second doctor – the shrink who was responsible for keeping me locked away from Isaac even though I was told that I could go home if I changed my mind about the admission – the man who lied and told me that Zoloft does not take effect fast enough to have been the culprit when I started questioning it – the man who told me he was forcing me to stay in the hospital against my will and there was nothing I could do about it, and that I could not go home until I became compliant with “my meds.” 

From 2002-2005 he took $11,590 from pharmaceutical companies. Many of these payments were for “honoraria” and “research projects.” So, Dr. G… how did the research turn out? How many dead women and babies did your research produce?

http://extra.twincities.com/CAR/doctors/default.asp

      PFIZER INC 2002 HONORARIA, PROFESSIONAL CONSULTING FEES, PAYMENT FOR REASONABLE EXPENSES FOR SERVING ON FACULTY OR OTHERWISE PARTICIPATING AT A PROFESSIONAL OR EDUCATIONAL CONFERENCE, MEETING OR RESEARCH PROJECT $1,500.00
      ASTRAZENECA PHARMACEUTICALS 2004 COMPENSATION FOR SERVICES $1,000.00
      ASTRAZENECA PHARMACEUTICALS 2004 COMPENSATION FOR SERVICES $1,000.00
      PFIZER INC 2004 HONORARIA, PROFESSIONAL CONSULTING FEES, PAYMENT FOR REASONABLE EXPENSES FOR SERVING ON FACULTY OR OTHERWISE PARTICIPATING AT A PROFESSIONAL OR EDUCATIONAL CONFERENCE, MEETING OR RESEARCH PROJECT $518.25
      PFIZER INC 2004 HONORARIA, PROFESSIONAL CONSULTING FEES, PAYMENT FOR REASONABLE EXPENSES FOR SERVING ON FACULTY OR OTHERWISE PARTICIPATING AT A PROFESSIONAL OR EDUCATIONAL CONFERENCE, MEETING OR RESEARCH PROJECT $515.00
      ASTRAZENECA PHARMACEUTICALS 2005 COMPENSATION FOR SERVICES $7,000.00
      ASTRAZENECA PHARMACEUTICALS 2005 EXPENSE REIMBURSEMENT $56.70

Filed under: Amy Philo, Isaac Philo, pharma payments to doctors

Donate: Stop Preventable Infant Deaths and Birth Defects

Click here to lend your support to: Stop Preventable Infant Deaths and Birth Defects and make a donation at www.pledgie.com !

Be a Facebook Fan!

UNITE FOR LIFE Fan Page

UNITE FOR LIFE Fan Page

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 728 other followers

Get the latest from the Fiddaman blog

Archives

UNITE News

November 2014
M T W T F S S
« Sep    
 12
3456789
10111213141516
17181920212223
24252627282930

Where Do People See This Blog?

Protect babies from drugs

Eli Lilly Funds Depression Screening Initiatives

depredrugshirt

Matthew Schultz killed by Effexor. Two hours old.

More Photos

Big Pharma Victim

  • I haven't been on in awhile thanks to all those who followed 4 years ago
  • @LindsayRush yay IOWA! 4 years ago
  • Another rainy day here in IOWA. Well at least i had a good time swimmin yesterday. 4 years ago
  • Hey everyone hope you have a great day! THanks to all the new followers :) and for those that continue to follow 4 years ago
  • srry if I dont get on here much I mostly just look at my facebook acct. thanks to all the new followers! 4 years ago

The Indiana Star

Christiane Schultz

  • Is not coping well at all. Loss sucks! 5 years ago
  • is scared to bond with this baby, just in case. 5 years ago
  • Happy 6 months today baby. I love you Matthew. 5 years ago
  • Living with loss, sucks. 5 years ago
  • Thinking I need to discuss plans for this baby soon or I will be having it in my doctors office. Where do I deliver? 5 years ago

Amery Schultz

Seeking Parents in Missouri for Celexa / Lexapro Class Action – Call 800-827-0087

TWEET FOR LIFE

BREATH – The Official Blog of MADNAP – momsandmeds.com

RSS BREATH

  • Untitled
    Originally posted on The Bitter Pill:Kickstarter is a website for artists to use to raise money and complete awesome projects. The best thing to come to the informed consent movement since Thomas Szasz could just be the new, upcoming film by Dan Jenski, “ADDicted” which basically gives Ritalin, Adderall, Concerta and the like a…
  • Untitled
    Originally posted on The Bitter Pill:In the studies submitted to the FDA for approving Zoloft (a drug that has killed numerous families, babies, mothers, children), the drug maker covered up the fact that Zoloft failed to outperform placebo, according to a new consumer fraud lawsuit filed by the firms Baum, Hedlund Aristei & Goldman…
  • Antidepressants Again Linked to Preterm Birth & Seizures
    In what was more than likely originally an attempt to prove that depression causes birth complications, researchers from Yale, Tufts, et al found in two new studies that antidepressants increase the risk of preterm birth and seizures. Read more at this link on the newly redesigned UNITE website.
  • Who Could Do This On Purpose
    Read this blog to find out
  • Canadian Regulation on Fetal Exposure to Psychotropic Drugs – Public Input Needed
    Canadian Regulation on Fetal Exposure to Psychotropic Drugs – Public Input Needed (Cross-Posted on The Bitter Pill blog) Amery and Christiane Schultz have been asked to provide input on proposed recommendations regarding psychotropic drugs in pregnancy in Canada. Amery & Christiane are hard-working activists affiliated with UNITE and MADNAP. Please send […]

UNITE ARCHIVES – Victims & Survivors Against The MOTHERS Act: YouTube Playlist

Videos: Psych Drugs, Birth Defects, Infant Death, Violence & Suicide

UNITE ARCHIVES – Add Your Group To The Coalition Against The MOTHERS Act

CADIMA: 54 Groups and Counting!

UNITE ARCHIVES – The MOTHERS Act Citizen Voting Area on Open Congress

Status: 76% AGAINST S. 324 The MOTHERS Act. Vote & Comment.

UNITE ARCHIVES – Join the Coalition Against The MOTHERS Act on Facebook!

3,271 Facebook Members and Counting!

UNITE ARCHIVES – Stop The Dangerous and Invasive MOTHERS Act!

13,500 Signatures and Counting!

Follow

Get every new post delivered to your Inbox.

Join 728 other followers

%d bloggers like this: